Skip to contentSkip to filters

We use cookies for analytics.

FDA Grand Rounds presented by the Office of Women’s Health: FDA Menopausal Hormone Therapy (MHT) Labeling: Historical Context and Recent Changes

Nicholas Hazen, M.D. and Aisha Johnson, M.D., MPH, MBA

Center for Drug Evaluation and Research, U.S. Food and Drug Administration

Recording

46 min

Abstract

How did the Women’s Health Initiative change the labeling of menopausal hormone therapy? The speakers trace the clinical evidence and regulatory history and explain the reasoning for changes across four product categories.

Topics